4.6 Article

A core outcome set for pre-eclampsia research: an international consensus development study

Journal

Publisher

WILEY
DOI: 10.1111/1471-0528.16319

Keywords

Consensus development study; core outcome set; modified Delphi method; modified nominal group technique; outcome reporting bias; pre-eclampsia

Funding

  1. Barts Charity
  2. National Institute for Health Research
  3. Elisabeth Garrett Anderson Hospital Charity
  4. MRC [MR/P027938/1] Funding Source: UKRI

Ask authors/readers for more resources

Objective To develop a core outcome set for pre-eclampsia. Design Consensus development study. Setting International. Population Two hundred and eight-one healthcare professionals, 41 researchers and 110 patients, representing 56 countries, participated. Methods Modified Delphi method and Modified Nominal Group Technique. Results A long-list of 116 potential core outcomes was developed by combining the outcomes reported in 79 pre-eclampsia trials with those derived from thematic analysis of 30 in-depth interviews of women with lived experience of pre-eclampsia. Forty-seven consensus outcomes were identified from the Delphi process following which 14 maternal and eight offspring core outcomes were agreed at the consensus development meeting. Maternal core outcomes: death, eclampsia, stroke, cortical blindness, retinal detachment, pulmonary oedema, acute kidney injury, liver haematoma or rupture, abruption, postpartum haemorrhage, raised liver enzymes, low platelets, admission to intensive care required, and intubation and ventilation. Offspring core outcomes: stillbirth, gestational age at delivery, birthweight, small-for-gestational-age, neonatal mortality, seizures, admission to neonatal unit required and respiratory support. Conclusions The core outcome set for pre-eclampsia should underpin future randomised trials and systematic reviews. Such implementation should ensure that future research holds the necessary reach and relevance to inform clinical practice, enhance women's care and improve the outcomes of pregnant women and their babies. Tweetable abstract @HOPEoutcomes 281 healthcare professionals, 41 researchers and 110 women have developed #preeclampsia @jamesmnduffy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Implementing two-stage consent pathway in neonatal trials

Eleanor Mitchell, Sam J. Oddie, Jon Dorling, Chris Gale, Mark John Johnson, William McGuire, Shalini Ojha

Summary: This article describes the implementation of a two-stage consent pathway in the FEED1 trial and the steps taken by the trial team to support sites. Recommendations for future trials considering a similar pathway are also provided.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2023)

Article Acoustics

Longitudinal Doppler Assessments in Late Preterm Fetal Growth Restriction

Bronacha Mylrea-Foley, Hans Wolf, Tamara Stampalija, Christoph Lees

ULTRASCHALL IN DER MEDIZIN (2023)

Article Pediatrics

Parents' Experiences of Communication in Neonatal Care (PEC): a neonatal survey refined for real-time parent feedback

Susanna Sakonidou, Sophia Kotzamanis, Amy Tallett, Alan J. Poots, Neena Modi, Derek Bell, Chris Gale

Summary: This study aimed to refine an existing retrospective survey for 'real-time' feedback in assessing parent experiences of neonatal services. The revised Parents' Experiences of Communication in Neonatal Care (PEC) survey contains 28 questions (10 new) focusing on communication and parent involvement. Developed with parents, it is the first UK instrument formally evaluated to assess parent experience while infants are still receiving neonatal care.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2023)

Article Medicine, Research & Experimental

Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children

Katharine Cheng, Fenna Mahler, Irja Lutsar, Begonya Nafria Escalera, Stefanie Breitenstein, Gilles Vassal, Joana Claverol, Nuria Noel Palacio, Ron Portman, Gavin Pope, Martijn Bakker, Tessa van Der Geest, Mark A. A. Turner, Saskia N. N. de Wildt

Summary: Many medicines are used off-label in children outside the terms of the license. The Conect4children project aims to establish a pan-European pediatric clinical trial network to facilitate the development of new medicines for children. The project has successfully set up a multidisciplinary advice service, including the input of young patients and families, to optimize pediatric trial development and provide valuable advice to trial sponsors.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Correction Obstetrics & Gynecology

The Italian guidelines on ultrasound in obstetrics and gynecology: Executive summary of recommendations for practice (vol, 279,pg 176, 2022)

Anna Aprile, Giuseppe Cali, Nicola Chianchiano, Valentina Chiappa, Paola Corbella, Vincenzo D'Addario, Andrea Dall'Asta, Valentina De Robertis, Caterina Exacustos, Alessandra Familiari, Anna Fichera, Chiara Formigoni, Tiziana Frusca, Tullio Ghi, Stefano Guerriero, Ambra Iuculano, Francesco Labate, Pasquale Martinelli, Giovanni Monni, Maddalena Morlano, Francesco Nonino, Claudiana Olivieri, Dario Paladini, Cristina Peddes, Federico Prefumo, Giuseppe Rizzo, Mariangela Rustico, Laura Sarno, Irene Sciacovelli, Andrea Sciarrone, Tamara Stampalija, Fabrizio Taddei, Tullia Todros, Herbert Valensise, Patrizia Vergani, Nicola Volpe, Paolo Volpe, Carmela Votino, Germano Bettoncelli, Gabriella Bracalente, Monica Collini Ceccatelli, Mariapaola Costantini, Antonino D'Aloia, Enrico Ferrazzi, Claudio Giorlandino, Mariavittoria Locci, Carla Verrotti di Pianella, Elsa Viora, Riccardo Zoia, Katia Bilardo, Maria Vicar

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2023)

Review Peripheral Vascular Disease

The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league

James E. Sharman, Pedro Ordunez, Tammy Brady, Gianfranco Parati, George Stergiou, Paul K. Whelton, Raj Padwal, Michael Hecht Olsen, Christian Delles, Aletta E. Schutte, Maciej Tomaszewski, Daniel T. Lackland, Nadia Khan, Richard J. McManus, Ross T. Tsuyuki, Xin-Hua Zhang, Lisa D. Murphy, Andrew E. Moran, Markus P. Schlaich, Norm R. C. Campbell

JOURNAL OF HUMAN HYPERTENSION (2023)

Article Pharmacology & Pharmacy

Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence-A contribution from the ConcePTION project

Evelina Cardoso, Anaelle Monfort, Ema Ferreira, Hedvig Nordeng, Ursula Winterfeld, Karel Allegaert, Peggy Gandia, Monia Guidi, Alice Panchaud

Summary: Human milk is the best nutrition for infants, and taking medication postpartum is common. Discontinuing breastfeeding is often wrongly advised due to concerns of adverse effects on the infant, even though only a few drugs are strictly prohibited while breastfeeding. Most drugs are transferred from the mother's blood to the milk, but the amount ingested by the infant is usually small. As there is limited population-based evidence on drug safety during breastfeeding, risk assessment relies on available clinical evidence, pharmacokinetic principles, and specialized sources of information for clinical decision-making. Risk assessment should consider both the potential risk to the infant and the benefits and risks associated with breastfeeding and maternal disease. Identifying situations with potential for drug accumulation in the infant is crucial for risk assessment. Healthcare providers should assume maternal concerns and utilize risk communication to ensure medication adherence without interrupting breastfeeding unnecessarily. Decision support algorithms and strategies can be used to minimize drug exposure in the breastfed infant, even when clinically not justified.

THERAPIE (2023)

Letter Obstetrics & Gynecology

Restrictive use of labor induction in absence of proven benefit

Renee J. Burger, Anita C. J. Ravelli, Sanne J. Gordijn, Wessel Ganzevoort

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2023)

Article Obstetrics & Gynecology

Does Day 3 embryo status matter to reproductive outcomes of single blastocyst transfer cycles? A cohort study

Jiaxin Qiu, Tong Du, Haiyan Guo, Ben W. W. Mol, Jiaying Lin, Dong Zhao, Yun Wang, Yanping Kuang, Wentao Li

Summary: This study aimed to investigate the impact of Day 3 embryo status on reproductive outcomes of blastocyst transfer cycles. The findings showed that high-quality blastocysts derived from poor-grade Day 3 embryos had comparable pregnancy outcomes to those derived from high-grade Day 3 embryos. However, cycles with low Day 3 cell number (five cells or fewer) had a significantly higher miscarriage rate compared to cycles with eight cells on Day 3.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Editorial Material Obstetrics & Gynecology

Intervention to address cardiovascular risk following hypertensive pregnancy

L. A. Magee, P. von Dadelszen

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Obstetrics & Gynecology

Clinical outcomes after fresh versus frozen embryo transfer in women with advanced reproductive age undergoing in vitro fertilization: a propensity score-matched cohort study

Chunyan Sun, Mingming Ye, Yuanyuan Wu, Qiaoyu Chen, Zhenzhen Meng, Lulu Geng, Orhan Bukulmez, Ben W. Mol, Xiaoming Teng, Miaoxin Chen

Summary: This retrospective cohort study aimed to compare clinical outcomes following fresh or frozen embryo transfer (FET) in women with advanced reproductive age (ARA). The results showed that FET did not improve live birth and other clinical outcomes as compared with fresh embryo transfer in women with ARA who underwent their first IVF cycle.

HUMAN FERTILITY (2023)

Editorial Material Primary Health Care

Analysis Underserved 'Deep End' populations: a critical analysis addressing the power imbalance in research

Caroline Mitchell, Kate Fryer, Nicola Guess, Habiba Aminu, Ben Jackson, Anna Gordon, Josephine Reynolds, Qizhi Huang, Shamanthi Jayasooriya, Rebecca Mawson, Tom Lawy, Emma Linton, Janet Brown

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Peripheral Vascular Disease

Association Between Chronic Hypertension and the Risk of 12 Cardiovascular Diseases Among Parous Women: The Role of Adverse Pregnancy Outcomes

Sukainah Al Khalaf, Lucy C. C. Chappell, Ali S. S. Khashan, Fergus P. P. McCarthy, Eilis J. O'Reilly

Summary: There is a strong association between chronic hypertension and the risk of cardiovascular disease (CVD) in mothers, especially those with adverse pregnancy outcomes (APOs). This risk can lead to premature CVD, thus intervention programs targeting these high-risk groups might reduce their risk of subsequent CVD.

HYPERTENSION (2023)

Review Obstetrics & Gynecology

Management of preterm labor: Clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation

Themistoklis Dagklis, Ranjit Akolekar, Cecilia Villalain, Ioannis Tsakiridis, Assaad Kesrouani, Aydin Tekay, Walter Plasencia, Sven Wellmann, Satoshi Kusuda, Nelly Jekova, Federico Prefumo, Nicola Volpe, Petya Chaveeva, Karel Allegaert, Asma Khalil, Cihat Sen

Summary: This practice guideline aims to improve the management of preterm labor and provides further guidance for healthcare practitioners on diagnosing preterm labor and the appropriate use of medications.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2023)

Article Obstetrics & Gynecology

Inherited episodic ataxia type 2 in pregnancy: A case report

Margaret Mascherpa, Anna Fichera, Rossana Orabona, Daniela Recupero, Barbara Borroni, Franco Edoardo Odicino, Federico Prefumo

Summary: An optimal materno-neonatal outcome was achieved in a pregnancy involving inherited episodic ataxia through a multidisciplinary team managing the timing and mode of delivery.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

No Data Available